Evidence map›Paper›PMID 30171413›Full record

GuidelineEsophagus : official journal of the Japan Esophageal Society2019

Esophageal cancer practice guidelines 2017 edited by the Japan Esophageal Society: part 1.

Yuko Kitagawa, Takashi Uno, Tsuneo Oyama, Ken Kato, Hiroyuki Kato, Hirofumi Kawakubo, Osamu Kawamura, Motoyasu Kusano, Hiroyuki Kuwano, Hiroya Takeuchi and 10 more

Erratum issuedAbstract readPractice Guideline
PubMed Full text at PMC Publisher
In one paragraph

Guideline in Esophagus : official journal of the Japan Esophageal Society, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 280 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
280citing papers in PubMed, 6 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

280 citing papers in PubMed, 6 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Does thoracoscopic esophagectomy really reduce post-operative pneumonia in all cases?Esophagus : official journal of the Japan Esophageal Society · 2021
    Pooled it
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Article
  19. Article
  20. BBS5 as a robust prognostic biomarker in esophageal squamous cell carcinoma: validation in two independent cohorts.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Article

220 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors.

Yuko KitagawaDepartment of Surgery, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan. kitagawa@a3.keio.jp.
Takashi UnoDepartment of Radiology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Tsuneo OyamaDepartment of Gastroenterology, Saku Central Hospital, Nagano, Japan.
Ken KatoGastrointestinal Medical Oncology Division, National Cancer Center Hospital, Tokyo, Japan.
Hiroyuki KatoDepartment of Gastrointestinal Tract Surgery, Fukushima Medical University School of Medicine, Fukushima, Japan.
Hirofumi KawakuboDepartment of Surgery, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.
Osamu KawamuraDepartment of Endoscopy and Endoscopic Surgery, Gunma University Hospital, Maebashi, Gunma, Japan.
Motoyasu KusanoDepartment of Endoscopy and Endoscopic Surgery, Gunma University Hospital, Maebashi, Gunma, Japan.
Hiroyuki KuwanoDepartment of General Surgical Science, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan.
Hiroya TakeuchiDepartment of Surgery, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan.
Yasushi TohDepartment of Gastroenterological Surgery, National Kyushu Cancer Center, Fukuoka, Japan.
Yuichiro DokiDepartment of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Yoshio NaomotoDepartment of General Surgery, Kawasaki Medical School, Okayama, Japan.
Kenji NemotoDepartment of Radiation Oncology, Yamagata University School of Medicine, Yonezawa, Japan.
Eisuke BookaDepartment of Surgery, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.
Hisahiro MatsubaraDepartment of Frontier Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan.
Tatsuya MiyazakiDepartment of General Surgical Science, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan.
Manabu MutoDepartment of Clinical Oncology, Kyoto University Hospital, Kyoto, Japan.
Akio YanagisawaDepartment of Pathology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Masahiro YoshidaDepartment of Hemodialysis and Surgery, Chemotherapy Research Institute, International University of Health and Welfare, Ichikawa, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AlgorithmsEsophageal NeoplasmsEsophageal StenosisEsophagoscopyHumansIncidenceJapanNeoplasm InvasivenessNeoplasm StagingPostoperative ComplicationsRisk FactorsCancerEsophagusPractice guidelines

Identifiers

PMID30171413
PMCPMC6510883

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.